User menu

Hyperammonemic encephalopathy after adjunction of phenobarbital to chronic topiramate and oxcarbazepine therapy.

Bibliographic reference Hantson, Philippe ; Frederick, Anne ; Van Rijckevorsel, Germaine. Hyperammonemic encephalopathy after adjunction of phenobarbital to chronic topiramate and oxcarbazepine therapy.. In: Acta Neurologica Belgica, Vol. 115, no. 4, p. 777-778 (2015)
Permanent URL http://hdl.handle.net/2078.1/171957
  1. Adams Erin N., Marks Alla, Lizer Mitsi H., Carbamazepine-induced hyperammonemia, 10.2146/ajhp080454
  2. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Mishima Nobuyuki, Yazawa Rei, Inoue Kazuyuki, Itoh Kunihiko, Kagawa Yoshiyuki, Inoue Yushi, Risk factors for hyperammonemia in pediatric patients with epilepsy, 10.1111/epi.12125
  3. Hamer H. M., Knake S., Schomburg U., Rosenow F., Valproate-induced hyperammonemic encephalopathy in the presence of topiramate, 10.1212/wnl.54.1.230
  4. Coppola Giangennaro, Epifanio Giuseppina, Auricchio Gianfranca, Federico Rosario Romualdo, Resicato Gianluca, Pascotto Antonio, Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet, 10.1016/j.braindev.2005.11.005
  5. Hug George, McGraw Catherine A., Bates Stephen R., Landrigan Evelyn A., Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children, 10.1016/s0022-3476(05)80306-3
  6. Warter J. M., Marescaux Ch., Brandt Ch., Rumbach L., Micheletti G., Chabrier G., Imler M., Kurtz D., Sodium Valproate Associated with Phenobarbital: Effects on Ammonia Metabolism in Humans, 10.1111/j.1528-1157.1983.tb03428.x